Dr Reddys Laboratories (RDY) Short-term Investments (2014 - 2026)

Dr Reddys Laboratories' Short-term Investments history runs 13 years deep, the most recent figure standing at $1.7 million for Q1 2026.

• In Q1 2026, Short-term Investments fell 73.64% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $1.7 million (down 73.64% YoY), while the FY2026 annual figure was $772.0 million, up 10928.57% from the prior year.
• Short-term Investments was $1.7 million for Q1 2026 at Dr Reddys Laboratories, down from $32.5 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $681.5 million in Q1 2023 to a low of -$589.6 million in Q3 2022.
• Historically, Short-term Investments has averaged $19.6 million across 5 years, with a median of $7.6 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Short-term Investments slumped 3872.64% in 2022, then jumped 2588.38% in 2023.
• A 5-year view of Short-term Investments shows it stood at -$589.6 million in 2022, then surged by 101.5% to $8.8 million in 2023, then slumped by 45.99% to $4.8 million in 2024, then soared by 580.81% to $32.5 million in 2025, then slumped by 94.79% to $1.7 million in 2026.
• The last three Short-term Investments figures came in at $1.7 million (Q1 2026), $32.5 million (Q3 2025), and $6.4 million (Q1 2025), per Business Quant data.